India Sweden city Oxford covid-19 vaccine Department India Sweden city Oxford

COVID-19 vaccine: Three candidates are at final trials and show 'good results'

Reading now: 209
www.livemint.com

Oxford University's COVID-19 vaccineOfficially dubbed as AZD1222, the COVID-19 vaccine has been developed by the Jenner Institute, a part of the Nuffield Department of Medicine at the University of Oxford.

The formulation is backed by by AstraZeneca PLC, a British-Swedish pharmaceutical company. The vaccine has shown positive results in the initial trial.

The vaccine candidate is safe and prompts protective immune response, according to a report in The Lancet.AstraZeneca has joined Serum Institute of India (SII), the world's largest vaccine manufacturers by number of doses produced and sold, to produce the potential vaccine in India.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA